English
Italiano
ROSSELLA
FIORAVANTI
gli studenti si ricevono tutti i giorni previo appuntamento via mail
| Course | Code | Year | Course - Attendance |
|---|---|---|---|
| Complements of medicinal and toxicological chemistry | 1045024 | 2021/2022 | Pharmacy |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2021/2022 | Pharmacy |
| PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES | 1023914 | 2021/2022 | Biotechnologies |
| Complements of medicinal and toxicological chemistry | 1045024 | 2020/2021 | Pharmacy |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2020/2021 | Pharmacy |
| PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES | 1023914 | 2020/2021 | Biotechnologies |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2019/2020 | Pharmacy |
| Complements of medicinal and toxicological chemistry | 1045024 | 2019/2020 | Pharmacy |
| PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES | 1023914 | 2019/2020 | Biotechnologies |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2018/2019 | Pharmacy |
| Complements of medicinal and toxicological chemistry | 1045024 | 2018/2019 | Pharmacy |
| ANALYSIS OF ACTIVE SUBSTANCES IN MEDICINAL AND AROMATIC PLANTS | 1022988 | 2017/2018 | Applied Pharmaceutical Sciences |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2017/2018 | Pharmacy |
| Complements of medicinal and toxicological chemistry | 1045024 | 2017/2018 | Pharmacy |
| PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES | 1023914 | 2017/2018 | Biotechnologies |
| ANALYSIS OF ACTIVE SUBSTANCES IN MEDICINAL AND AROMATIC PLANTS | 1022988 | 2016/2017 | Applied Pharmaceutical Sciences |
| ANALYSIS OF DRUGS WITH LABORATORY II | 1026160 | 2016/2017 | Pharmacy |
| Complements of medicinal and toxicological chemistry | 1045024 | 2016/2017 | Pharmacy |
| PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES | 1023914 | 2016/2017 | Biotechnologies |
| Title | Journal | Year |
|---|---|---|
| Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation | CANCERS | 2020 |
| Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation | CHEMMEDCHEM | 2020 |
| Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation | SCIENCE ADVANCES | 2020 |
| Design of first-in-class dual EZH2/HDAC inhibitor: biochemical activity and biological evaluation in cancer cells | ACS MEDICINAL CHEMISTRY LETTERS | 2020 |
| Targeting histone acetylation/deacetylation in parasites: an update (2017–2020) | CURRENT OPINION IN CHEMICAL BIOLOGY | 2020 |
| Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 Inhibitors and Induced apoptosis in cancer cells | MOLECULES | 2020 |
| CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas | FRONTIERS IN PHARMACOLOGY | 2020 |
| Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity | CHEMMEDCHEM | 2020 |
| Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells | CLINICAL EPIGENETICS | 2019 |
| design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol-4-yl-methylaniline derivatives | FRONTIERS IN CHEMISTRY | 2019 |
| Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype | CLINICAL EPIGENETICS | 2019 |
| Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo | MOLECULAR NEUROBIOLOGY | 2019 |
| Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer | CURRENT OPINION IN CHEMICAL BIOLOGY | 2019 |
| Six years (2012-2018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds | THE CHEMICAL RECORD | 2018 |
| Inhibitors of yellow fever virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: design, synthesis and antiviral evaluation | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017 |
| (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2016 |
| 3-(Phenyl-4-oxy)-5-phenyl-4,5-dihydro-(1H)-pyrazole: a fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part I. Structure-enantioselectivity relationships | JOURNAL OF CHROMATOGRAPHY A | 2016 |
| N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)anilines: a novel class of anti-RSV agents | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015 |
Department
CHIMICA E TECNOLOGIE DEL FARMACO
Downloads
SSD
CHIM/08